Skip to main content
. 2021 Oct 28;12:100253. doi: 10.1016/j.lanepe.2021.100253

Fig. 2.

Fig 2

Percentage of fatigue, headache, local pain, and myalgia/muscle in younger and older placebo recipients, compared to the vaccine arms. Percentage (95% CI) of solicited AEs in younger and older placebo recipients, compared to the vaccine arms, of mRNA based vaccines (first doses) and viral vector vaccine considering fatigue, headache, local pain, and myalgia/muscle pain.